WEREWOLF THERAPEUTICS, INC. Contract with Customer, Liability, Noncurrent
WEREWOLF THERAPEUTICS, INC. (HOWL) had Contract with Customer, Liability, Noncurrent of $0 as of 2024-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:ContractWithCustomerLiabilityNoncurrent · last filed 2025-03-11
- 2024-12-31: Contract with Customer, Liability, Noncurrent $0.00.
- 2024-09-30: Contract with Customer, Liability, Noncurrent $0.00.
- 2024-06-30: Contract with Customer, Liability, Noncurrent $0.00.
- 2024-03-31: Contract with Customer, Liability, Noncurrent $431.00K.
| Period end | Contract with Customer, Liability, Noncurrent |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-11 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-07 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 |
| 2024-03-31 | $431.00K 10-Q · filed 2024-05-03 |
| 2023-12-31 | $433.00K 10-K · filed 2025-03-11 |
| 2023-09-30 | $588.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $783.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $1.17M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.13M 10-K · filed 2024-03-07 |
| 2022-09-30 | $343.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $1.25M 10-Q · filed 2022-08-11 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |